Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1Phase 1 1

Status

Unknown 3Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 5Head & Neck 3

Conditions

Esophageal Neoplasms 2Resectable Pancreatic Cancer 1Rectal Neoplasms 1Pancreatic Neoplasms 1

Interventions

Oxaliplatin 1004Fluorouracil 800Capecitabine 764Gemcitabine 650Leucovorin 559Irinotecan 537Bevacizumab 513Radiotherapy 460Cisplatin 440Drug Therapy 298Cetuximab 280Surgical Procedures, Operative 229Paclitaxel 228S 1 (combination) 217pembrolizumab 205Docetaxel 199130-nm albumin-bound paclitaxel 196Nivolumab 193sintilimab 191Radiosurgery 190lenvatinib 180Folfox protocol 179Sorafenib 178Albumin-Bound Paclitaxel 173apatinib 170tislelizumab 161camrelizumab 160Neoadjuvant Therapy 158Blood Specimen Collection 154durvalumab 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Chemoradiotherapy, Adjuvant × Gastrointestinal × Clear all
NCT05667298 2026-05-11

OPERARADIO

University of Manitoba

Phase 1 Active not recruiting
11 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT06427447 2025-02-04

ADJUPANC

Changhai Hospital

Phase 3 Recruiting
770 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT04737551 2021-02-04

Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study

Shanghai Zhongshan Hospital

Unknown
400 enrolled
Gastrointestinal

Resectable Pancreatic Cancer

NCT02371304 2020-05-21

TESAR

Amsterdam UMC, location VUmc

Phase 3 Unknown
302 enrolled
Gastrointestinal

Rectal Neoplasms

NCT01463501 2013-05-14

Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer

Zhejiang Cancer Hospital

Phase 2 Unknown
60 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡